1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Mercy Center for Corrective Eye Surgery: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| UVA-Riboflavin Crosslinking Treatment of Corneal Ectasia UV-X Light, Riboflavin - Keratoconus, Ectasia | Phase 2 | Unknown | Mercy Center for Corrective Eye Surgery | 250 | 2011-03-01 | 2011-03-29 |
Corneal Diseases (1) · Dilatation, Pathologic (1) · Eye Diseases (1) · Keratoconus (1)
Riboflavin (1)
United States (1)
PMID 16765803, PMID 16952090, PMID 18471635, PMID 18811118, PMID 20138607, PMID 20164744